MARKET

CYBN

CYBN

Cybin Inc
AMEX
6.99
-0.07
-0.99%
After Hours: 7.17 +0.18 +2.58% 18:28 04/25 EDT
OPEN
7.06
PREV CLOSE
7.06
HIGH
7.20
LOW
6.91
VOLUME
146.10K
TURNOVER
--
52 WEEK HIGH
14.44
52 WEEK LOW
4.810
MARKET CAP
146.97M
P/E (TTM)
-1.7591
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Clearmind completes clinical site initiations for AUD trial
TipRanks · 2d ago
Cybin Expands Strategic Partnerships for Phase 3 MDD Treatment Trials
TipRanks · 3d ago
Cybin announces additional CYB003 strategic partnership agreements
TipRanks · 3d ago
Cybin Announces Additional Strategic Partnership Agreements To Support PARADIGM, Multinational Phase 3 Program Evaluating CYB003
Benzinga · 3d ago
CYBIN - ENGAGES 18 CLINICAL SITES FOR PHASE 3 PROGRAM EVALUATING CYB003 FOR THE ADJUNCTIVE TREATMENT OF MDD
Reuters · 3d ago
CYBIN INC - SECOND PHASE 3 STUDY EMBRACE EXPECTED TO BEGIN MID-2025
Reuters · 3d ago
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
Barchart · 3d ago
Reported Earlier: 'Texas Lawmakers Take Up Bills To Expedite Access To Psychedelic Therapy' - Marijuana Moment
Benzinga · 4d ago
More
About CYBN
More
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.
Recently
Symbol
Price
%Change

Webull offers Cybin Inc stock information, including AMEX: CYBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYBN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYBN stock methods without spending real money on the virtual paper trading platform.